Genetic Thrombophilia Variants and Risk for Preeclampsia Among American Indians

REFERENCES

• Gammill HS, Roberts JM. Emerging concepts in preeclampsia investigation. Front Biosci 2007; 12: 2403–2411
   PubMed Web of Science ®Google Scholar
• Ilekis JV, Reddy UM, Roberts JM. Preeclampsia—a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop. Reprod Sci 2007; 14: 508–523
   PubMed Web of Science ®Google Scholar
• Levy MT, Jacober SJ, Sowers JR. Hypertensive disorders of pregnancy in southwestern Navajo Indians. Arch Intern Med 1994; 154: 2181–2183
   PubMedGoogle Scholar
• ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002; 77: 67–75
   PubMed Web of Science ®Google Scholar
• Chesley LC, Cooper DW. Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women. Br J Obstet Gynaecol 1986; 93: 898–908
   PubMedGoogle Scholar
• Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993; 4: 59–61
   PubMed Web of Science ®Google Scholar
• Arngrimsson R, Björnsson S, Geirsson RT, Björnsson H, Walker JJ, Snaedal G. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol 1990; 97: 762–769
   PubMedGoogle Scholar
• Bertina R M, Koeleman B P C, Koster T, Rosendaal F R, Dirven R J, de Ronde H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64–67
   PubMed Web of Science ®Google Scholar
• Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt B. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 1994; 343: 1361–1362
   PubMed Web of Science ®Google Scholar
• Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133–1134
   PubMed Web of Science ®Google Scholar
• Cox MJ, Rees DC, Martinson JJ, Clegg JB. Evidence for a single origin of factor V Leiden. Br J Haematol 1996; 92: 1022–1025
   Google Scholar
• De Stefano V, Rossi E, Paciaroni K, Leone G. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica 2002; 87: 1095–1108
   PubMed Web of Science ®Google Scholar
• Donahue BS, Gailani D, Higgins MS, Drinkwater DC, George AL, Jr. Factor V Leiden protects against blood loss and transfusion after cardiac surgery. Circulation 2003; 107: 1003–1008
   Google Scholar
• Dizon-Townson DS, Nelson LM, Easton K, Ward K. The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996; 175: 902–5
   PubMed Web of Science ®Google Scholar
• Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P, et al. Thromb Haemost 1997; 77: 1052–1054
   PubMed Web of Science ®Google Scholar
• Lin J, August P. Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 2005; 105: 182–192
   PubMed Web of Science ®Google Scholar
• GOPEC Consortium. Disentangling fetal and maternal susceptibility for pre-eclampsia: a British multicenter candidate-gene study. Am J Hum Genet 2005; 77: 127–131
   PubMed Web of Science ®Google Scholar
• Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3-prime-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698–3703
   PubMed Web of Science ®Google Scholar
• Roberts JM, Pearson G, Cutler J. Lindheimer M; NHLBI Working Group on Research on Hypertension During Pregnancy. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 2003; 41: 437–445
   PubMed Web of Science ®Google Scholar
• Bodnar LM, Catov JM, Roberts JM. Racial/ethnic differences in the monthly variation of preeclampsia incidence. Am J Obstet Gynecol 2007; 196: 324, e1–5
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Althabe F, Belizán JM, Kafury-Goeta AC. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am J Obstet Gynecol 1999; 181: 1026–1035
   PubMed Web of Science ®Google Scholar
• Hegele RA, Harris SB, Cao H, Hanley AJ, Zinman B. Factor V Leiden (F5 Q506) and vascular disease in Canadian Oji-Cree. Diabetes Care 1998; 21: 1203
   PubMedGoogle Scholar
• Kohler HP, Boothby M, McCormack L, Knowler WC, Grant PJ. Incidence of Arg506 --> Gln mutation (factor V Leiden) in Pima Indians. Thromb Haemost 1997; 78: 961–962
   Google Scholar
• Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 1997; 277: 1305–1307
   PubMed Web of Science ®Google Scholar
• Gregg JP, Yamane AJ, Grody WW. Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations. Am J Med Genet 1997; 73: 334–346
   PubMed Web of Science ®Google Scholar
• deMaat MPM, Kluft C, Jespersen J. World Distribution of factor V Leiden mutation. Lancet 1996; 347: 58
   Google Scholar
• Souto JC, Coll I, Llobet D, del Río E, Oliver A, Mateo J, et al. The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population. Thromb Haemost 1998; 80: 366–369
   PubMed Web of Science ®Google Scholar
• Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998; 79: 706–708
   PubMed Web of Science ®Google Scholar
• Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation 1999; 99: 999–1004
   PubMedGoogle Scholar
• Cnattingius S, Reilly M, Pawitan Y, Lichtenstein P. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study. Am J Med Genet A 2004; 130: 365–371
   Google Scholar
• Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 9–13, Erratum in: N Engl J Med 1999; 341:384
   PubMed Web of Science ®Google Scholar
• De Groot CJ, Bloemenkamp KW, Duvekot EJ, Helmerhorst FM, Bertina RM, Van Der Meer F, et al. Preeclampsia and genetic risk factors for thrombosis: a case-control study. Am J Obstet Gynecol 1999; 181: 975–980
   PubMed Web of Science ®Google Scholar
• Kim YJ, Williamson RA, Murray JC, Andrews J, Pietscher JJ, Peraud PJ, et al. Genetic susceptibility to preeclampsia: roles of cytosineto-thymine substitution at nucleotide 677 of the gene for ethylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine beta-synthase, and factor V Leiden mutation. Am J Obstet Gynecol 2001; 184: 1211–1217
   PubMed Web of Science ®Google Scholar
• Robertson L, Wu O, Greer I. Thrombophilia and adverse pregnancy outcome. Curr Opin Obstet Gynecol 2004; 16: 453–458
   PubMed Web of Science ®Google Scholar
• Dudding TE, Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. Thromb Haemost 2004; 91: 700–711
   PubMed Web of Science ®Google Scholar
• Chappell S, Morgan L. Searching for genetic clues to the causes of pre-eclampsia. Clin Sci (Lond) 2006; 110: 443–458
   PubMed Web of Science ®Google Scholar